Sample results
Pancreatic beta cell hyperplasia is a rare condition characterized by an abnormal increase in insulin-producing beta cells in the pancreas. It is caused by the excessive proliferation of these beta cells, leading to overproduction of insulin and C-peptide. The C-Peptide Serum test is the most important test for diagnosing this condition because it directly measures endogenous insulin production from pancreatic beta cells.
Pancreatic beta cell hyperplasia is caused by the abnormal proliferation and increase in the number of insulin-producing beta cells in the pancreas. This excessive growth of beta cells leads to overproduction of insulin, which can result in persistent hypoglycemia or low blood sugar episodes. The exact triggers for this abnormal cell growth can vary, but the condition results in an overactive pancreas that produces more insulin than the body needs, causing blood sugar levels to drop dangerously low.
The C-Peptide Serum test is the most important test for pancreatic beta cell hyperplasia because it directly measures the amount of insulin your pancreas naturally produces. C-peptide is released in equal amounts with insulin from beta cells, so elevated C-peptide levels indicate excessive insulin production from the increased number of beta cells. This test is particularly valuable because C-peptide is not affected by external insulin administration and has a longer half-life than insulin itself, making it a more reliable marker for assessing pancreatic beta cell function and diagnosing conditions involving beta cell hyperactivity.
You should get tested if you experience frequent episodes of low blood sugar, especially symptoms like shakiness, sweating, confusion, dizziness, or fainting that occur between meals or during fasting. Testing is also important if you have unexplained hypoglycemia that happens without a clear cause like diabetes medication or excessive exercise. Anyone with recurrent low blood sugar episodes that improve after eating, or those experiencing severe hypoglycemia requiring emergency treatment, should pursue C-peptide testing to evaluate pancreatic beta cell function.
What this means
Your C-Peptide level is below the optimal range, indicating that your pancreas is producing less insulin than ideal. This may suggest diminished pancreatic beta cell function, which is common in type 1 diabetes or advanced type 2 diabetes, and may explain difficulties with blood sugar control.
Recommended actions
Discuss insulin therapy options with your healthcare provider or endocrinologist
Focus on a balanced diet with consistent carbohydrate portions to manage blood sugar
Monitor your blood glucose regularly to track patterns and response to meals
Consider retesting C-Peptide in 3-6 months to monitor pancreatic function trends
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Personal Lab Guide
Quick questions: